311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review
STAT reporter Jason Mast joins us to discuss Anthony Fauci's memoir "On Call," which was published this week. Hosts Allison DeAngelis and Adam Feuerstein also dissect Alnylam's forthcoming clinical tr...
20 Jun 202434min
310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)
STAT's Nicholas Florko joins to explain what it means to be a reporter writing about the commercial determinants of health. Hint: Florko's most recent stories focus on weed, vapes, and raw milk. And i...
13 Jun 202438min
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update
STAT colleague Meghana Keshavan joins us to dissect Lykos Therapeutics' meeting with an FDA advisory committee. We also discuss the latest news in the health and life sciences, including stories from ...
6 Jun 202429min
308: An ASCO preview & another Duchenne trial failure
We preview some of the research that will be presented at The American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a ...
30 Mai 202428min
307: More tumult at BIO & coercive care for sickle cell patients
This week on “The Readout LOUD,” STAT's Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also ...
23 Mai 202431min
306: Live! From the STAT Breakthrough Summit West
On this week’s "Readout LOUD," we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent ...
16 Mai 202423min
305: Everything you need to know about H5N1 bird flu
This week on "The Readout LOUD," STAT senior infectious diseases reporter Helen Branswell walks us through ongoing H5N1 outbreak in the U.S. and issues with monitoring the spread. And in a bit of sham...
9 Mai 202431min
304: Controversial brain tissue research, obesity drug sales and Novartis’ M&A drama
The removal of small amounts of brain tissue from desperately ill patients, done as part of a Mount Sinai research project, triggered alarm bells at the Food and Drug Administration and has raised bro...
2 Mai 202433min
